個人檔案
學歷
- 1997-2004 國立陽明大學醫學系醫學士
經歷
- 2025.08- 臺北醫學大學臺北癌症中心淋巴癌及血癌團隊召集人
- 2022.08- 臺北醫學大學醫學系內科學科血液腫瘤科主任
- 2020.09- 衛生福利部雙和醫院內科部血液腫瘤科主任
- 2019.08- 臺北醫學大學醫學系內科學科助理教授
- 2013.02-2019.07 臺北醫學大學醫學系內科學科講師
- 2012- 衛生福利部雙和醫院化療安全小組召集人
- 2012- 衛生福利部雙和醫院血液腫瘤科病房主任
- 2011-2013 臺北醫學大學醫學系兼任講師
- 2011.09-2012.07 國立陽明大學醫學系兼任講師
- 2010- 臺北醫學大學署立雙和醫院血液腫瘤科主治醫師
- 2010 台北榮民總醫院血液腫瘤科主治醫師
- 2007-2010 台北榮民總醫院血液腫瘤科總醫師
- 2004-2007 台北榮民總醫院內科住院醫師
- 2002 國際醫學生大會籌備會委員
- 2002 中華民國醫學生聯合會國際交換學生至挪威Tromsoe大學附設醫院
獎項
- 2009 第14屆亞太骨髓移植學會傑出壁報論文獎
研究興趣
- 臨床試驗
- 腸胃道癌症臨床資料研究
- 腸胃道癌症藥物抗藥性探討
指紋
- 1 類似的個人檔案
過去五年中的合作和熱門研究領域
-
靶向MIR31HG/LncHIFCAR 相關分子網絡在胰腺癌轉移和腫瘤微環境的研究－靶向致癌性非編碼核醣核酸 MIR31HG/miR-31分子調控網絡以增進胰臟癌治療效果(3/3)
Hsieh, Y.-Y. (PI)
8/1/25 → 7/31/26
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
-
-
針對BTK/BCL2L11 axis的雙重標的對順鉑頑固型耐藥食道癌細胞的意義
Hsieh, Y.-Y. (PI)
8/1/24 → 7/31/25
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
-
靶向MIR31HG/LncHIFCAR 相關分子網絡在胰腺癌轉移和腫瘤微環境的研究-靶向致癌性非編碼核醣核酸 MIR31HG/miR-31分子調控網絡以增進胰臟癌治療效果 (2/3)
Hsieh, Y.-Y. (PI)
8/1/24 → 7/31/25
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
-
布鲁頓酪氨酸激酶(Bruton's tyrosine kinase , BTK)對頑固型耐藥食道癌細胞鐵死亡敏感性之機制研究
Hsieh, Y.-Y. (PI)
8/1/23 → 7/31/24
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
-
Correction to: Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma: A Potential Theranostic Biomarker (Diagnostics, (2023), 13, 13, (2296), 10.3390/diagnostics13132296)
Ong, K. H., Hsieh, Y. Y., Sun, D. P., Huang, S. K. H., Tian, Y. F., Chou, C. L., Shiue, Y. L., Joseph, K. & Chang, I. W., 2月 2025, 於: Diagnostics. 15, 3, 391.研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審
開啟存取 -
Machine Learning-Based Survival Analysis for Patients Receiving Lenvatinib for Unresectable Hepatocellular Carcinoma
Lu, C. H., Chang, C. W., Chen, S. C., Kao, W. Y., Ting, W. Y., Lu, C. H., Chuang, K. I., Ni, C. F., Hsieh, Y. Y., Wu, M. S., Su, C. W., Chang, C. C. & Wu, C. H., 1月 5 2025, 於: Journal of Hepatocellular Carcinoma. 12, p. 2625-2637 13 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Predicting Survival Outcomes in Patients with Hepatocellular Carcinoma Receiving Lenvatinib by Using the Up7-ALBI Score
Lu, C. H., Kao, W. Y., Wu, C. H., Ting, W. Y., Lu, C. H., Chuang, K. I., Ni, C. F., Hsieh, Y. Y., Wu, M. S., Su, C. W. & Chen, S., 2025, (接受/付印) 於: Liver Cancer. 14, 6, p. 704-717 14 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取4 連結會在新分頁中開啟 引文 斯高帕斯（Scopus） -
Sarcopenia and myosteatosis are associated with low survival in patients receiving lenvatinib for unresectable hepatocellular carcinoma
Luo, P. J., Chuang, K. I., Ni, C. F., Yeh, H. Y., Wu, M. S., Hsieh, Y. Y., Kao, W. Y. & Wu, C. H., 9月 2025, 於: Journal of the Formosan Medical Association = Taiwan yi zhi. 124, 9, p. 800-808 9 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取8 連結會在新分頁中開啟 引文 斯高帕斯（Scopus） -
The clinicopathological significance and prognostic impact of 14-3-3σ/stratifin expression on patients with surgically resectable intrahepatic cholangiocarcinoma
Wang, S. H., Hsieh, Y. Y., Ong, K. H., Lai, H. Y., Tsai, H. H., Sun, D. P., Huang, S. K. H., Tian, Y. F., Wu, H. C., Chan, T. C., Joseph, K. & Chang, I. W., 1月 2025, 於: Asian Journal of Surgery. 48, 1, p. 250-260 11 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取
資料集
-
Supplementary data from Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining
Liu, T.-P. (Contributor), Hsieh, Y.-Y. (Contributor), Chou, C.-J. (Contributor) & Yang, P.-M. (Contributor), Unknown Publisher, 1月 1 2018
DOI: 10.6084/m9.figshare.7375601.v1, https://rs.figshare.com/articles/Supplementary_data_from_Systematic_polypharmacology_and_drug_repurposing_via_an_integrated_L1000-based_Connectivity_Map_database_mining/7375601/1
資料集: Dataset
-
Supplementary data from Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining
Liu, T.-P. (Contributor), Hsieh, Y.-Y. (Contributor), Chou, C.-J. (Contributor) & Yang, P.-M. (Contributor), Unknown Publisher, 1月 1 2018
DOI: 10.6084/m9.figshare.7346312.v1, https://rs.figshare.com/articles/journal_contribution/Supplementary_data_from_Systematic_polypharmacology_and_drug_repurposing_via_an_integrated_L1000-based_Connectivity_Map_database_mining/7346312/1
資料集: Dataset
-
Supplementary material from "Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining"
Liu, T.-P. (Contributor), Hsieh, Y.-Y. (Creator), Chou, C.-J. (Contributor) & Yang, P.-M. (Creator), Figshare, 2018
DOI: 10.6084/m9.figshare.c.4302764.v2, https://figshare.com/collections/Supplementary_material_from_Systematic_polypharmacology_and_drug_repurposing_via_an_integrated_L1000-based_Connectivity_Map_database_mining_/4302764/2
資料集: Dataset
-
Supplementary material from "Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining"
Liu, T.-P. (Contributor), Hsieh, Y.-Y. (Creator), Chou, C.-J. (Contributor) & Yang, P.-M. (Creator), Figshare, 2018
DOI: 10.6084/m9.figshare.c.4302764.v1, https://figshare.com/collections/Supplementary_material_from_Systematic_polypharmacology_and_drug_repurposing_via_an_integrated_L1000-based_Connectivity_Map_database_mining_/4302764/1
資料集: Dataset
-
Supplementary data from Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining.
Liu, T.-P. (Contributor), Yang, P.-M. (Creator), Hsieh, Y.-Y. (Creator) & Chou, C.-J. (Contributor), The Royal Society, 2018
DOI: 10.6084/m9.figshare.7346312.v2, https://doi.org/10.6084%2Fm9.figshare.7346312.v2
資料集: Dataset